A Study to Explore the Safety And Tolerability of Doses of E2007 Up to a Maximum of 8 mg In Patients With Parkinson's Disease Who Experience End-of-Dose Wearing Off Motor Fluctuations
Clinical trial NCT00165789 · COMPLETED
Trial details
- NCT number
- NCT00165789
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2006-02-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.